Pharmacovigilance in Azerbaijan
Local PV coordination, safety information handling, literature and regulatory monitoring.
Pharmacovigilance Services across the CIS, EAEU, and Türkiye are essential for pharmaceutical companies seeking to maintain regulatory compliance, ensure patient safety, and manage local drug safety obligations effectively.
URAS PV provides comprehensive pharmacovigilance support to Marketing Authorization Holders (MAHs), pharmaceutical manufacturers, and international partners operating across these regions.
Our expertise includes Local QPPV and EAEU QPPV services, Individual Case Safety Report (ICSR) management, local literature monitoring, pharmacovigilance system documentation, and regulatory support.
Through our regional expertise and coordinated operational approach, we help pharmaceutical companies establish and maintain reliable pharmacovigilance systems aligned with applicable national and regional requirements.
Local PV coordination, safety information handling, literature and regulatory monitoring.
Local PV coordination, literature monitoring and safety documentation.
Local PV coordination, ICSR support and EAEU pharmacovigilance requirements.
Local PV coordination, literature monitoring and EAEU requirements.
Local PV coordination, safety information handling and local reporting.
Local and global PV support, safety case management and regulatory coordination.
Local PV coordination, Ukrainian literature monitoring and safety reporting.
Local PV coordination, literature monitoring and regulatory documentation.
URAS PV supports pharmaceutical companies in managing their pharmacovigilance responsibilities across multiple regulatory jurisdictions. Our services are designed to facilitate effective safety reporting, regulatory compliance, and continuous oversight of medicinal product safety.
We support the appointment and coordination of qualified pharmacovigilance personnel in accordance with applicable local and regional requirements. Our approach facilitates communication between Marketing Authorization Holders, local representatives, and competent regulatory authorities.
URAS PV provides systematic monitoring of relevant local medical and pharmaceutical literature to identify potential safety information associated with medicinal products. Literature screening activities are conducted according to applicable requirements and documented procedures.
Our pharmacovigilance services include support for the collection, assessment, documentation, and reporting of suspected adverse drug reactions. We facilitate timely safety information exchange and coordination between relevant stakeholders.
We assist pharmaceutical companies with the preparation, maintenance, and coordination of pharmacovigilance documentation, including Pharmacovigilance System Master Files (PSMFs), Standard Operating Procedures (SOPs), and relevant safety agreements.
URAS PV supports Marketing Authorization Holders in understanding and fulfilling applicable pharmacovigilance obligations across their target markets. Our coordinated approach helps maintain operational consistency while addressing country-specific regulatory requirements.
Planning to place a product on these markets? Our regulatory affairs team supports new registrations, renewals and variations.
Drug registration servicesURAS PV provides central coordination and integrates country-level pharmacovigilance activities with the client’s global PV system. Depending on the market and project, local activities may be performed by URAS PV specialists or qualified in-country partners.
Where required by the operating model, local experts may communicate directly with the Marketing Authorisation Holder, while URAS PV coordinates processes, documentation and information exchange across the wider PV system. Responsibilities, reporting timelines, communication channels and data flows are defined in the applicable written agreements.
Pharmacovigilance requirements differ between countries and may change over time. Before engagement, URAS PV confirms the applicable local requirements, the designated responsible persons, the reporting process and the agreed deliverables for each market.
URAS PV supports pharmaceutical companies in navigating country-specific pharmacovigilance requirements while maintaining alignment with applicable international and regional standards.
Applicable obligations are evaluated according to the relevant market, product registration procedure, and Marketing Authorization Holder responsibilities.
Looking for a reliable pharmacovigilance partner across the CIS, EAEU and Türkiye?
URAS PV provides coordinated pharmacovigilance services tailored to the regulatory requirements, product portfolios, and operational needs of pharmaceutical companies and Marketing Authorization Holders.
Contact our team to discuss your pharmacovigilance requirements and explore potential cooperation opportunities.
Contact Us